177Lu-UU-40

N/A

Report date: 2025/10/21 15:09:13

Base Information

Drug Name177Lu-UU-40

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionCD44 antigen modulators

TargetsCD44 antigen

Therapy Area/IndicationsThyroid Carcinoma, Anaplastic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUppsala University

China Registration ClassN/A

Develop Information

Active CompaniesUppsala University

Inactive CompaniesN/A

Active IndicationsThyroid Carcinoma, Anaplastic

Inactive IndicationsN/A

Other Information

ATC CodeN/A